Socioeconomic factors such as education and income influence survival after a diagnosis and treatment of cervical cancer ([@bib19]; [@bib16]). Despite convincing evidence based on studies in several countries, more knowledge is needed about the underlying mechanisms by which socioeconomic position influences prognosis and how social and health-related aspects may interact. 'Socioeconomic position\' refers to the social and economic factors that influence what positions individuals or groups hold within the structure of a society ([@bib11]).

We previously showed that lower education was associated with advanced cervical cancer at the time of diagnosis ([@bib15]), suggesting that cancer stage partly explains social differences in survival. Apart from delayed diagnosis, more women with a lower social position also tend to have comorbid conditions and risky health behaviour, such as smoking, and these may influence incidence, comorbidity, treatment choice and survival after cervical cancer ([@bib1]; [@bib16]; [@bib25]). Further socioeconomic differences in access to treatment have been suggested ([@bib1]). Although this is less likely in a tax-paid public health care system; agreement about treatment, based on a doctor\'s recommendations given the patient\'s condition and on patient\'s understanding, may differ according to the patient\'s socioeconomic position.

Previous studies in this field involved area-level measures of socioeconomic position, with the risk of underestimating the effects of social factors; focused on ethnic differences or had limited clinical data on prognostic factors ([@bib37]; [@bib7]; [@bib10]; [@bib38]; [@bib30]; [@bib4]; [@bib29]; [@bib24]), illustrating the need for studies based on individual level socioeconomic data and detailed clinical information, which we present here. In this population-based study we utilised access to data from administrative registers and a nationwide clinical database, and we investigated whether any association between socioeconomic position and overall survival after cervical cancer existed and further whether such association could be explained by socioeconomic differences in cancer stage, surgical treatment, comorbidity or lifestyle factors.

Materials and methods
=====================

Study population
----------------

The study population was identified from the Danish Gynaecological Cancer database (DGCD), which covers 96% of gynaecological cancer cases in Denmark and was established in 2005 ([@bib13]). A total of 2141 cases of invasive cervical cancer diagnosed between 1 January 2005 and 31 December 2010 were retrieved. We excluded women if there was no registration date (*n*=10), if there was no information on cancer stage (*n*=11), if information on tumour histology was missing in the DGCD and in the nationwide Danish Pathology Register (DPR) and a diagnosis of cervical cancer could not be verified in the Danish Cancer Registry (*n*=5). We also excluded women if they had immigrated to (because of missing information on socioeconomic position) or emigrated from (due to missing information on vital status) Denmark within 2 years before diagnosis (*n*=30), if born before 1920 (before which date registers for socioeconomic data were incomplete) (*n*=36), if information on three socioeconomic variables of interest (education, income and cohabitation status) were missing (*n*=58) or if they were under 25 years of age and therefore considered not to have reached their final educational level or income (*n*=30). This left a total of 1961 patients to be included in the current analyses.

Cancer characteristics and treatment
------------------------------------

From the DGCD, we obtained the clinical cancer stage, tumour histology, type of surgical treatment and treating hospital and dates of staging and operation. All data were entered into the database by the hospital gynaecologists for clinical information and by a gynaecological pathologist for pathology. Staging was carried out according to the recommendations of the Fédération Internationale des Gynécologistes et Obstetristes (FIGO) ([@bib33]). Stage 1a cancers were staged from a cone biopsy, and more advanced stages were evaluated under general anaesthesia by a gynaecologist and a gynaecological oncologist ([@bib9]). Cancer stage was divided into four main FIGO stages for the descriptive statistics (I--IV). For 152 patients with missing information on tumour histology, histological information was searched in and retrieved from the DPR ([@bib3]), and the tumours were grouped into squamous cell carcinomas, adenocarcinomas and other types (including sarcomas and mixed types).

For a subgroup of patients with early-stage cancer (stage Ia1-Ib1) where operation is the recommended treatment strategy, we determined whether they received surgical treatment. As the chemo- and radiotherapy procedures recommended for more advanced cancer were underreported in the files of the DGCD and in the Danish National Patient register, NPR ([@bib13]), we did not include information on primary oncologic treatment in the analyses. According to the Danish National clinical guidelines ([@bib9]), stage Ia cancer can be treated with a minimum of conisation. For cancer stage Ia with vascular invasion seen on cone biopsy and for stage Ib1 the strategy is radical hysterectomy or trachelectomy with lymph node dissection. In Denmark, treatment is centralised in five centres ([@bib9]). The type of surgical treatment registered in DGCD was validated in NPR and checked manually in the medical files of DGCD in case of missing data or operations deviating the expected operation for a given cervical cancer type. Manually checks were done if treatment information was missing (*n*=22), if the operation type was registered as exploratory (*n*=3) or as 'other operation type\' (*n*=12), and for patients with stage Ib1 if they were only registered with conisation (*n*=11).

Other health-related factors
----------------------------

In order to estimate the burden of comorbidity, all somatic diagnoses other than cervical cancer were retrieved from the NPR, which contains data on all hospitalisations in Denmark since 1977 and all outpatient visits since 1995 ([@bib28]). Diagnoses were coded into a modified Danish version of the International Classification of Diseases version 8 (ICD-8) until 1993 and thereafter into ICD-10. We calculated the Charlson comorbidity index (CCI), which covers 19 selected conditions scored from 1 to 6 by degree of severity ([@bib5]), and all clinical conditions were summed until 1 year before the cancer diagnosis. Comorbidity was grouped into 0 (none), 1 and 2 and 3 or more.

Information on lifestyle factors at the time of diagnosis was obtained from the DGCD. Smoking was categorised into 'never smokers\', ex-smokers and current smokers; and body mass index (BMI) into normal (18.5--24.9), underweight (\<18.5), overweight (25--29.9) and obese (⩾30) for the analyses.

Socioeconomic indicators
------------------------

Information on socioeconomic factors was obtained from the Danish Civil Registration System and from registers on education and income kept by Statistics Denmark, which contain data for each individual, updated each year ([@bib2]; [@bib17]; [@bib32]). Information on indicators 2 years before cancer diagnosis was used to minimise any reverse effect of early disease symptoms on socioeconomic position. Three indicators were selected to cover different aspects of social influence on health: knowledge-related assets (education), material resources (income) and social support (cohabitation status) ([@bib27]; [@bib11]).

Highest attained level of education was categorised into short (7 or 9 years of mandatory primary school for patients born before and after 1958, respectively), medium (8 or 10--12 years, latest grade of primary school, secondary school or vocational education) and high (\>12 years of education). Disposable income was household income per person after taxation and interest, adjusted for the number of people in the household and deflated according to 2000 value of the Danish crown by the formula from the Danish ministry of Finance: deflated household income/no. of persons in household^0.6^. It was categorised into quartiles of the national gender-specific disposable household income per person distribution: lowest (1st quartile), middle (2nd--3rd quartile) and highest (4th quartile). Cohabitation status was categorised as living with a partner (married or cohabiting) and living without a partner (single, widowed or divorced), as mortality patterns were similar for these groups. Cohabiting was defined as, in the absence of marriage, two people of the opposite sex, over the age of 16 years, with a maximum 15 years of age difference, living at the same address with no other adult in residence.

Survival
--------

Data on age, emigration and vital status at 30 November 2011 were retrieved from the Civil Registration System ([@bib32]).

Statistical analysis
--------------------

Associations between socioeconomic factors and all cause mortality were analysed in survival models, and confounders and mediators were identified in a diagram of hypothesised causal relations ([Figure 1](#fig1){ref-type="fig"}). For the survival analyses, a four-step model was used in accordance with the diagram: In model 1, associations between each socioeconomic indicator and mortality were calculated with adjustment for age; in model 2, relevant socioeconomic confounders were adjusted for (i.e., income was adjusted for education and cohabitation status); in models 3 and 4, comorbidity and cancer stage were entered stepwise to analyse whether these factors mediate the association between socioeconomic factors and mortality. Because of a high proportion of missing in the lifestyle variables, in two sets of subgroup analyses, the first including only women for whom information was available on smoking (exclusion of *n*=229) and the second including only women for whom we had information on both smoking and BMI (exclusion of *n*=289), smoking status and BMI were entered stepwise. In a sensitivity analysis, we re-ran the main models (1--4) in the subgroups to ensure that the extent to which comorbidity and stage explained the survival differences was equal to that in the main results.

Cox regression analysis was used to estimate hazard rate ratios (HRs) for death by all causes. Patients were followed from the date of diagnosis (either date of diagnostic staging or date of operation if staging date was not registered) in DGCD until date of death, emigration or end of follow-up. Time since diagnosis was used as the underlying time scale. Two-sided 95% confidence intervals (CIs) were calculated for the HRs with the Wald test of the Cox regression parameter. The assumptions of proportional hazards were tested graphically for each of the covariates. When reviewed graphically the effect of the three socioeconomic factors was equal over time from diagnosis, except for the graphs for income that were crossing at about 4.5 months after diagnosis; however, hazard ratios (HRs) for income was tested not significantly different before and after this time. Age was modelled as a continuous factor. Adjustment for cancer stage was done allowing separate underlying hazards for each stage (FIGO Ia1-IVb). All models were adjusted for a cluster effect of diagnosis and treatment at the same hospital with the robust sandwich covariance estimate.

We hypothesised that interactions between socioeconomic and health-related factors might exist and figured that mortality might be higher in patients who were both socially disadvantaged and had high age, severe comorbidity or advanced cancer. Therefore, effect modification between each of the three socioeconomic variables with age (in four groups), stage (four FIGO stages) and comorbidity (CCI 0, 1, 2 and 3+) were tested one at a time with age in the model using the Wald test statistics.

For the treatment outcome, whether receiving surgical treatment was analysed descriptively for a subgroup of 1056 patients with early cancer.

The analyses were carried out in SAS 9.3 with the PHREG procedures, and *P*\<0.05 was considered statistically significant.

Results
=======

The 1961 cervical cancer patients were followed up for a median of 3.0 (0.01--7.0) years, during which time 476 patients (24%) died by all causes. More deaths during follow-up were observed among women who were older, had shorter education, had lower disposable income, lived without partner, had advanced cancer stage, had comorbid conditions, were smokers, were underweight, had oncological treatment or were categorised as 'unknown\' for any indicator ([Table 1](#tbl1){ref-type="table"}).

[Table 2](#tbl2){ref-type="table"} specifies the distribution of comorbid conditions among the 359 women with a comorbidity score of ⩾1.

Of 1056 patients with cancer stage (Ia1-Ib1), 555 underwent radical hysterectomy with lymphadenectomy, 252 a simple hysterectomy, 70 a trachelectomy, 140 only a conisation, 2 patients had a laparoscopic lymphadenectomy because of positive lymph nodes at PET/CT, 1 was operated for cancer in the cervical stump (previous hysterectomy for benign condition) and 32 were referred to primary oncologic treatment because of more advanced disease found before planned surgery, in the following disease course or because of comorbidity. Four patients (all stage Ib1) received no treatment or only conisation because of patient decline or severe comorbidity ([Table 1](#tbl1){ref-type="table"}).

[Table 3](#tbl3){ref-type="table"} (model 2) shows that education and income were significantly associated with survival, the adjusted HR for short education being 1.46 (1.20--1.77) and that for lower income being 1.32 (1.07--1.63). Significant interactions were found between age and cohabitation status (*P*\<0.0001), age and income (*P*\<0.0001) and stage and income (*P*\<0.0001). For cohabitation and income, the results were shown separately for age\<60, and the adjusted HR of women aged\<60 years living without a partner was significantly increased 1.60 (1.29--1.98) over that for cohabiting women. The effect of income declined from lower to higher age groups. The age-adjusted HRs for income in categories of age were \<40 years (HR, 1.92; 0.70--5.31), 40--60 years (HR, 1.69; 1.40--2.05), 60--80 years (HR, 1.55; 1.11--2.19) and ⩾80 years (HR, 1.36; 0.49--3.76). The effect of income also declined from lower to higher stages; and among a small group of patients with stage IV cancer, there was no survival difference by income (stratified results are not shown).

Inclusion of comorbidity had a minor influence on the associations between socioeconomic factors and survival. When cancer stage was entered, the HR for shorter rather than higher education was 1.07 (0.96--1.19), the HR for lowest rather than highest income was 1.15 (0.86--1.52) and the HR for women aged\<60 years living without a partner was 1.42 (1.16--1.74) ([Table 3](#tbl3){ref-type="table"}, models 3 and 4).

When smoking was included in the subgroup analysis, the estimated HR for women with shorter education was 0.89 (0.75--1.05), for lower income was 0.95 (0.74--1.21) and for living without a partner was 1.24 (1.01--1.52) as compared with women with longer education, higher income and cohabiting women, respectively ([Table 3](#tbl3){ref-type="table"}, subgroup results). Inclusion of BMI did not change these estimates further; for example, the HR for women with shorter education was 0.89 (0.76--1.05) (data not shown). However, the age-adjusted association between each socioeconomic factor and mortality was weaker in these subgroups than in the main analysis. The age-adjusted HRs were 1.36 (1.07--1.74) for short education and 1.29 (0.98--1.71) for lowest income, but similar for cohabitation status; and these estimates were slightly lower after exclusion of women for whom BMI information was missing. The size of the extent to which comorbidity and stage influenced the relations was close to those in the main analysis (data not shown).

Discussion
==========

In this nationwide study of women with cervical cancer, short education, lower income and living without a partner were related to shorter survival. These socioeconomic differences in survival were explained mostly by cancer stage and to a lesser extent by smoking and comorbidity, leaving only a tendency to differences in survival by cohabitation status, after adjustment. As only a few patients with early-stage cancer were not given first-line treatment, we suggest that there are no socioeconomic differences in who undergo first-line treatment for early cervical cancer.

Significant socioeconomic differences in survival was found in most other cohorts of cervical cancer patients, higher mortality being associated with a shorter education, lower income; indicators of lower social position or living in areas with poverty ([@bib37]; [@bib10]; [@bib4]; [@bib39]; [@bib29]; [@bib23]; [@bib36]) and being unmarried or living alone ([@bib20]; [@bib14]; [@bib29]; [@bib31]; [@bib23]). Although there are exceptions in studies using area-level data, a composite social measure and with focus on older patients ([@bib7]; [@bib24]).

With regard to possible mediating factors, we found that most of the association between education or income and survival was due to cancer stage. In comparison, two studies from the USA found a tendency to survival disparities by community poverty level after adjustment for cancer characteristics and under treatment (HR, 1.21; 0.97--1.51) ([@bib4]) and 1.20 (0.88--1.64) ([@bib29]). Whereas another study showed considerable survival differences by area-level socioeconomic status after adjustment for stage (HR, 1.9; 1.6--2.3) ([@bib10]); however, data on stage were missing for 17% of women and stage was dichotomised with the possibility of selection bias and residual mediation. Further it was found that differences in survival by marital status varied by stage, the largest differences being for patients with early-stage cancer ([@bib31]). We found a similar nonsignificant tendency to an effect modification between cohabitation status and stage (data not shown). Studies in Norwegian and US patients showed that survival differences between single and married women were partly explained by stage (never married, HR, 1.48; 1.05--2.09; divorced, 1.25, 0.99--1.57) ([@bib21]; [@bib20]) and by both stage and treatment (HR, 1.15; 1.02--1.26) ([@bib14]). We also found a small elevated mortality among single rather than married or cohabiting women after adjustment for important prognostic factors. One suggestion is that this tendency is due to differences in access to or compliance with oncological treatment, which we could not account for in our data, because social support may be more critical for patients receiving a series of treatments than for those whose cancer is managed definitively by surgery ([@bib31]). Another possible reason is that these patients are somehow more vulnerable from the beginning of treatment with respect to unmeasured health-related factors that are not captured in the comorbidity index.

The finding that cancer stage is the most important factor affecting socioeconomic differences in cervical cancer survival points to explanations such as patients or primary care doctors delay due to lower screening participation, delayed health care-seeking behaviour, less reporting of symptoms or late referral to specialist care ([@bib8]), which is supported by findings of social disparities in cervical cancer screening and in symptom recognition and awareness ([@bib34]; [@bib35]; [@bib26]). However, our previous study on same data showed that lower screening participation only explained a relatively small part of the socioeconomic differences in cervical cancer diagnosis stage ([@bib15]).

In our study, smoking appeared to have a greater impact on socioeconomic differences in survival than comorbidity. In comparison, comorbidity was found to have no impact on the social disparities in mortality after cervical cancer in a Swedish population ([@bib23]); whereas smokers compared with nonsmokers had a significantly higher all cause mortality (35%, age-, stage- and treatment-adjusted) among US cervical cancer patients ([@bib6]), corresponding to our results. With the relatively low age of this patient group, and most patients diagnosed in early cancer stages, comorbidity seems to have a limited influence on the survival disparities. On the other hand, it might be considered that the comorbidity index used is not sensitive enough to capture the burden of comorbidity; as CCI scores were calculated from in- and outpatient hospital contacts, diagnosis treated solely at general practitioner were not counted in. However, the index conditions are severe and would most likely be causes of contact with a hospital. Further, treatment opportunities have improved as the CCI weights were constructed; and also, with data based on NPR discharge diagnosis no differentiation was made between mildest *vs* severe cases of a given disorder. However, the clear stepwise survival difference between CCI scores 0 to ⩾3 as shown descriptively indicates that the CCI is valid for measuring the burden of comorbid disease in this patient group.

Smoking might be a proxy for comorbidity that is not captured in the index. Smoking-related comorbidity was frequent in this patient group ([Table 2](#tbl2){ref-type="table"}), but being a smoker could also be associated with reduced general health status due to both smoking and other lifestyle factors. Body mass index measured at the time of diagnosis did not appear to mediate the association, and alcohol consumption was underreported in the DGCD (data missing for 81%). The analyses of the impact of smoking were limited to women for whom information was available and excluding those with the highest mortality, which may have increased the apparent impact of smoking. We assumed, however, that smoking, which affects healing after surgery and radiotherapy, and to some extent comorbidity, influences social differences in survival after cervical cancer, secondary to the influence of cancer stage.

Recent studies from the US found diverging effects of marital status and neighbourhood income level on treatment outcomes ([@bib18]; [@bib40]; [@bib31]). In our study, the absolute number of patients with early cancer stage who did not receive first-line surgery was small, and all but four patients were referred to chemotherapy primarily for the findings of more advanced cancer or poor health condition. Thus, for this outcome there was no purpose of looking into socioeconomic differences, and we therefore suggest that there are no socioeconomic differences in who received first-line treatment for early cervical cancer.

Important strengths of the study are linkage of data in nationwide, population-based administrative registers by the unique Danish personal identification number, which minimised selection bias and misclassification of disease-related, lifestyle and socioeconomic information, whereas area-based measures were used in most previous studies on this topic, with a risk for misclassifying socioeconomic position ([@bib12]). In addition, the use of cohabitation status rather than marital status covered social influences from non-marital relationships and thereby minimised misclassification of social support from a partner ([@bib27]). Short comings of the study include missing information on oncological treatment and the basis for estimating burden of comorbidity; however, we suggest that this leave minor bias to the study results. Lastly, we used a standard method to examine the pathways from exposure through intermediate factors (stage, comorbidity and so on) to the mortality outcome, where we conditioned on these factors in regression analyses. In recent years, methods for a more precise quantification of mediating effects have been developed with the advantages of a more direct causal interpretation and with mathematical consistency ([@bib22]). However, such models have mostly been applied to problems of a more biological nature, whereas socioeconomic exposures could be measured in a number of ways. The pathways from socioeconomic exposures to outcomes are rarely simple, and many mediators and confounders could be identified. Also, to quantify a precise effect of a mediating variable (with narrow confidence limits) requires larger sample sizes than was available here.

In conclusion, socioeconomic differences in survival after cervical cancer were found in a population where ethnic homogeneity and universal access to health care exist. These socioeconomic differences were mostly explained by cancer stage and to a lesser extent by comorbidity and smoking. The results indicate the need for further investigations on how to reduce delays in diagnosis for disadvantaged groups and the importance of smoking prevention aimed at these groups. Finally, in general, health care professionals should pay attention to socially disadvantaged patients and patients without close supportive relationships during the cancer trajectory.
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###### Descriptive statistics of 1961 Danish patients with cervical cancer diagnosed between 2005 and 2010

  **Characteristics**                                      **All, *N*=1961 (%)**   **No. of deaths during follow-up, *n* (%)**
  -------------------------------------------------------- ----------------------- ---------------------------------------------
  **Age (years)[a](#t1-fn2){ref-type="fn"}**                                       
  25--39                                                   617 (32)                45 (7)
  40--59                                                   754 (38)                138 (18)
  60--79                                                   489 (25)                221 (45)
  ⩾80                                                      101 (5)                 72 (71)
  **Level of education[b](#t1-fn3){ref-type="fn"}**                                
  Short (7 or 9 years)                                     416 (21)                176 (42)
  Medium (8 or 10--12 years)                               1025 (52)               205 (20)
  Higher (⩾12 years)                                       473 (24)                74 (16)
  Missing                                                  47 (2)                  21 (45)
  **Disposable income[b](#t1-fn3){ref-type="fn"}**                                 
  Lowest (1st quartile)                                    560 (28)                162 (28)
  Middle (2nd--3rd quartiles)                              921 (47)                215 (23)
  Highest (4th quartile)                                   400 (21)                76 (19)
  Missing                                                  80 (4)                  23 (29)
  **Cohabitation status[b](#t1-fn3){ref-type="fn"}**                               
  Married or cohabiting                                    1216 (62)               241 (20)
  Single, widowed or divorced                              745 (38)                235 (32)
  **Year of diagnosis**                                                            
  2005                                                     336 (17)                111 (33)
  2006                                                     335 (17)                85 (25)
  2007                                                     333 (17)                99 (30)
  2008                                                     310 (16)                76 (25)
  2009                                                     348 (18)                68 (20)
  2010                                                     299 (15)                37 (12)
  **Tumour histology**                                                             
  Squamous cell carcinoma                                  1477 (76)               353 (24)
  Adenocarcinoma                                           366 (19)                76 (21)
  Other                                                    99 (5)                  34 (34)
  Unknown                                                  19 (1)                  13 (68)
  **Cancer stage (FIGO)**                                                          
  I                                                        1143 (58)               83 (7)
  II                                                       430 (22)                129 (30)
  III                                                      253 (13)                151 (60)
  IV                                                       135 (7)                 113 (84)
  **Comorbidity (CCI score)[c](#t1-fn4){ref-type="fn"}**                           
  0                                                        1602 (82)               315 (20)
  1                                                        215 (11)                83 (39)
  2                                                        89 (5)                  40 (45)
  ⩾3                                                       55 (3)                  38 (69)
  **Smoking status[a](#t1-fn2){ref-type="fn"}**                                    
  Never                                                    781 (40)                141 (18)
  Former smoker                                            297 (15)                58 (19)
  Current smoker                                           654 (33)                191 (29)
  Unknown                                                  229 (12)                86 (38)
  **Body mass index (BMI)[a](#t1-fn2){ref-type="fn"}**                             
  Underweight (\<18.5)                                     88 (4)                  42 (48)
  Normal (18.5--24.9)                                      994 (51)                213 (21)
  Overweight (25--29.9)                                    480 (25)                98 (20)
  Obesity (⩾30)                                            302 (15)                72 (24)
  Unknown                                                  97 (5)                  52 (54)
  **Treatment (cancer stages Ia1-Ib1) (*n*=1056)**                                 
  Radical hysterectomy                                     555 (53)                39 (7)
  Hysterectomy                                             252 (24)                16 (6)
  Trachelectomy                                            70 (7)                  0
  Conisation                                               140 (12)                3 (2)
  Other types of operation                                 3 (0)                   0
  No operation                                             4 (4)                   0
  Oncological treatment (referral)                         32 (3)                  9 (27)

Abbreviations: CCI=Charlson comorbidity index; FIGO=Fédération Internationale des Gynécologistes et Obstetristes.

Measured at the time of diagnosis.

Social factors were included 2 years before cancer diagnosis. *Education* was categorised into short (7 or 9 years of mandatory primary school education for patients born before or after 1958, respectively), medium (8 or 10--12 years, latest grade of primary school, secondary school or vocational education) and higher (⩾12 years of education). *Income* was categorised into lowest (1st quartile), middle (2nd--3rd quartiles) and highest (4th quartile).

Cumulated from 1977 and until 1 year before cancer diagnosis.

###### Clinical conditions used in calculating the Charlson comorbidity index (CCI) for 1961 patients with cervical cancer diagnosed between 2005 and 2010

  **Disorder**                                       **CCI weight**[a](#t2-fn1){ref-type="fn"}   **No. of patients**[b](#t2-fn2){ref-type="fn"}
  -------------------------------------------------- ------------------------------------------- ------------------------------------------------
  Myocardial infarction                              1                                           23
  Congestive heart failure                           1                                           12
  Peripheral vascular disease                        1                                           41
  Cerebrovascular disease                            1                                           67
  Dementia                                           1                                           3
  Chronic pulmonary disease                          1                                           98
  Connective tissue disease                          1                                           39
  Ulcer disease                                      1                                           40
  Mild liver disease                                 1                                           18
  Diabetes type 1 and type 2                         1                                           44
  Hemiplegia                                         2                                           1
  Moderate to severe renal disease                   2                                           20
  Diabetes type 1 and type 2 with end-organ damage   2                                           18
  Any tumour (other than cervical)                   2                                           52
  Leukaemia                                          2                                           1
  Lymphoma                                           2                                           6
  Moderate to severe liver disease                   3                                           1
  Metastatic solid tumour                            6                                           9
  AIDS                                               6                                           0

Weights for each condition that a patient has; the total is the score. For example: chronic pulmonary (1) and lymphoma (2)=total score (3).

On the basis of data from the Danish National Patient Register.

###### Associations between socioeconomic factors and mortality from all causes with inclusion of the potential mediators (comorbidity and cancer stage), among 1961 Danish women with cervical cancer diagnosed 2005--2010, and with inclusion of smoking for a subgroup of 1696 women

                                       **Model 1** **Adjustment for age** **HR (95% CI)**   **Model 2** **Adjusted** **HR (95% CI)**[a](#t3-fn2){ref-type="fn"}   **Model 3** **Adjusted**[b](#t3-fn3){ref-type="fn"}**+comorbidity** **HR (95% CI)**   **Model 4** **Adjusted**[c](#t3-fn4){ref-type="fn"}**+cancer stage** **HR (95% CI)**   **Subgroup results** **Adjusted +smoking status**[d](#t3-fn5){ref-type="fn"} **HR (95% CI)**
  ------------------------------------ ---------------------------------------------------- --------------------------------------------------------------------- ------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------
  **Level of education (*n*=1914)**                                                                                                                                                                                                                                                                                                            (*n*=1696)
  Higher                               1                                                    1                                                                     1                                                                                     1                                                                                      1
  Medium                               1.19 (0.92--1.54)                                    1.19 (0.92--1.54)                                                     1.20 (0.89--1.62)                                                                     1.03 (0.78--1.35)                                                                      0.91 (0.62-1.33)
  Short                                1.46 (1.20--1.77)                                    1.46 (1.20--1.77)                                                     1.44 (1.19--1.75)                                                                     1.07 (0.96--1.19)                                                                      0.89 (0.75--1.05)
  **Cohabitation status (*n*=1961)**                                                                                                                                                                                                                                                                                                           (*n*=1696)
  All                                                                                                                                                                                                                                                                                                                                          
   Married or cohabiting               1                                                    1                                                                     1                                                                                     1                                                                                      1
   Single, widowed, divorced           1.11 (1.00-1.23)                                     1.08 (0.97--1.20)                                                     1.01 (0.89--1.14)                                                                     0.97 (0.87--1.09)                                                                      1.02 (0.90-1.16)
  Age\<60                                                                                                                                                                                                                                                                                                                                      
   Married or cohabiting               1                                                    1                                                                     1                                                                                     1                                                                                      1
   Single, widowed, divorced           1.58 (1.26--1.98)                                    1.60 (1.29--1.98)                                                     1.59 (1.28--1.98)                                                                     1.42 (1.16--1.74)                                                                      1.24 (1.01--1.52)
  **Disposable income (*n*=1881)**                                                                                                                                                                                                                                                                                                             (*n*=1634)
  All                                                                                                                                                                                                                                                                                                                                          
   Highest (4th quartile)              1                                                    1                                                                     1                                                                                     1                                                                                      1
   Middle (2nd--3rd quartile)          1.15 (1.02--1.31)                                    1.09 (0.94--1.25)                                                     1.08 (0.97--1.20)                                                                     0.99 (0.87--1.12)                                                                      0.90 (0.72--1.11)
   Lowest (1st quartile)               1.44 (1.17--1.76)                                    1.32 (1.07--1.63)                                                     1.34 (1.12--1.62)                                                                     1.15 (0.86--1.52)                                                                      0.95 (0.74--1.21)
  Age\<60                                                                                                                                                                                                                                                                                                                                      
   Highest (4th quartile)              1                                                    1                                                                     1                                                                                     1                                                                                      1
   Lowest (1st quartile)               1.90 (1.45--2.51)                                    1.59 (1.29--1.95)                                                     1.56 (1.22--1.97)                                                                     1.08 (0.86--1.35)                                                                      0.80 (0.64--1.00)

Abbreviations: CI=confidence interval; HR=hazard ratio; FIGO=Fédération Internationale des Gynécologistes et Obstetristes.

Education adjusted for age; cohabitation status adjusted for age and education; income adjusted for age, education and cohabitation status.

Adjustments as in model 2 and additionally adjusted for Charlson comorbidity index.

Adjustments as in model 3 and additionally adjusted for cancer stage (FIGO).

Subgroup results including patients with information on smoking registered, results adjusted for smoking status, comorbidity and cancer stage (FIGO).
